Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Berthold Launches Mithras2 Multi-Technology Microplate Reader

Published: Friday, September 27, 2013
Last Updated: Friday, September 27, 2013
Bookmark and Share
Mithras2 LB943 with monochromator and filter technology.

Berthold Technologies has introduced the second generation of its Multimode Microplate Reader Mithras, the Mithras2 LB943 with monochromator and filter technology for these reading technologies
• UV/VIS Absorbance
• Fluorescence and FRET
• Fluorescence Polarization
• Time-Resolved Fluorescence (TRF and TR-FRET)
• Luminescence
• BRET and BRET²
• AlphaScreen® and AlphaLISA®

Already implemented in the TriStar² the patent-pending optical concept ONE-4-ALL is employed for sensitive luminescence, fluorescence and absorbance measurements - with performances as in dedicated instruments - in the Mithras² for filter-based reading.

Additionally the instrument is equipped with two double monochromators with high blocking efficiency and high f-number (increased transmission) for filter-less measurements of absorbance and fluorescence.

For utmost sensitivity in luminescence a third specially selected and extremely noise-reduced detector is engaged in the HiSens position which is used for Alpha and BRET readings, too.

Compared to its predecessor the optics has been improved once again to achieve improved detection limits
• Less than 2 amol ATP per well
• Less than 0.2 fmol Fluorescein per well
• Less than 2 amol Europium per well

Mithras² offers the possibility to use optical filters for luminescence measurements (of course, for all fluorescence and absorbance readings, too) enabling the sensitive measurement of BRET (e.g. functional assays in GPCR research) and multi-coloured luciferases (reporter gene assays).

Each individual filter is coded with an RFID tag and can be positively identified - a significant contribution to correct measurements and to secure quality standards.

Up to 4 reagent injectors with the proven and highly accurate JET technology complete the unit. The injector tips are located in reading position enabling the accurate measurement of very fast reactions.

A new feature is the reagent compartment at the front which keeps the reagents within easy reach and which can be filled with ice to keep them cooled. Reagent mounts hold small reagent containers safely in place and a slight inclination of the mount ensures tubings recover the last droplet.

Cellular assays are taken account of by a universal bottom reading function, a temperature control unit with an incubation compartment for the microplate and gas connectors.

Thus, the Mithras2 is a microplate reader offering comprehensive possibilities and a multitude of applications. The measurement of enzyme activities, phagocytosis, calcium flux, cell viability, apoptosis, immunoassays protein and nucleic acid concentrations and protein-protein interactions are only a few of the manifold fields of application the instrument offers.

The unit is operated with the approved Mikrowin software. Single and multiple endpoint measurements can be performed as well as kinetic and scanning measurements. The data can be displayed numerically and graphically and may be exported to EXCEL or printed.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
Testing for Malaria or Cancer at Home
Chemist develops tech to save lives in rural Africa.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!